Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome
Open Access
- 23 September 2020
- journal article
- research article
- Published by Pakistan Journal of Medical Sciences in Pakistan Journal of Medical Sciences
- Vol. 36 (7) , 1460-1465
Abstract
Objective: This study was aimed to compare the clinical outcomes of ovulation induction (OI) by timed intercourse with letrozole (LTZ) and clomiphene citrate (CC). Methods: Three hundred and twenty-three patients with polycystic ovary syndrome (PCOS) who underwent OI with LTZ or CC between February 2017 and November 2018 were included in this retrospective study. The patients were divided into two groups as the CC group (n=148) and the LTZ group (n=175). Endometrial thickness, follicular development, ovulation, clinical pregnancy, abortion, and live birth rates of the groups were analyzed. Results: The mean endometrium thickness of the CC group was 7.1±1.7 mm, and the LTZ group was 8.6±1.8 mm (p<0.001). The ovulation rate per cycle was higher in the LTZ group (93.1%) in comparison with the CC group (83.8%) (p=0.013). Clinical pregnancy rates were 52% in the LTZ group, and 41.2% in the CC group (p=0.047). LTZ with 44% of live birth rate was superior to CC with a 33% live birth rate (p=0.029). Conclusions: LTZ is an effective OI agent in PCOS patients. LTZ is superior to CC in terms of pregnancy rates and live birth rates. As a result, we recommend that LTZ should be the first-line treatment agent in patients with PCOS. doi: https://doi.org/10.12669/pjms.36.7.3345 How to cite this:Sakar MN, Oglak SC. Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome. Pak J Med Sci. 2020;36(7):1460-1465. doi: https://doi.org/10.12669/pjms.36.7.3345 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Keywords
This publication has 22 references indexed in Scilit:
- Diagnostic criteria for PCOS: Is there a need for a rethink?Best Practice & Research Clinical Obstetrics & Gynaecology, 2016
- Mono-ovulation in women with polycystic ovary syndrome: a clinical review on ovulation inductionReproductive BioMedicine Online, 2016
- Letrozole versus clomiphene citrate in polycystic ovary syndrome: systematic review and meta-analysisGynecological Endocrinology, 2015
- Frequency and outcome of treatment in polycystic ovaries related infertilityPakistan Journal of Medical Sciences, 2015
- Prevalence of Infertility and Use of Fertility Treatment in Women with Polycystic Ovary Syndrome: Data from a Large Community-Based Cohort StudyJournal of Women's Health, 2015
- Minimal Stimulation Using Gonadotropin Combined with Clomiphene Citrate or Letrozole for Intrauterine InseminationYonsei Medical Journal, 2015
- Current evidence supporting "letrozole" for ovulation inductionJournal of Human Reproductive Sciences, 2013
- Endometrial receptivity defects during IVF cycles with and without letrozoleHuman Reproduction, 2012
- A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndromeJournal of Human Reproductive Sciences, 2012
- Clomiphene citrate elicits estrogen agonistic/antagonistic effects differentially via estrogen receptors .ALPHA.and .BETA.Endocrine Journal, 2010